Loading clinical trials...
Loading clinical trials...
Phase III Study of Radiation Therapy With or Without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
Conditions
Interventions
temozolomide
3-dimensional conformal radiation therapy
+1 more
Locations
168
United States
UAB Comprehensive Cancer Center
Birmingham, Alabama, United States
Arizona Oncology Services Foundation
Phoenix, Arizona, United States
Rebecca and John Moores UCSD Cancer Center
La Jolla, California, United States
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, United States
Aurora Presbyterian Hospital
Aurora, Colorado, United States
St. Anthony Central Hospital
Denver, Colorado, United States
Start Date
November 17, 2009
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
September 8, 2025
NCT07390071
NCT06706102
NCT00602667
NCT00683319
NCT07416188
NCT04150913
Lead Sponsor
Eastern Cooperative Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions